{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:57:55Z","timestamp":1786121875668,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004257","name":"Western Norway Regional Health Authority","doi-asserted-by":"publisher","award":["F-12621"],"award-info":[{"award-number":["F-12621"]}],"id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003506","name":"Norwegian Ministry of Health and Care Services","doi-asserted-by":"publisher","award":["2022207"],"award-info":[{"award-number":["2022207"]}],"id":[{"id":"10.13039\/501100003506","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005036","name":"Universitetet i Bergen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005036","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010586","name":"Haukeland\u00a0Universitetssjukehus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Infectious Diseases"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/s1473-3099(26)00244-6","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:55:09Z","timestamp":1784242509000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Nirmatrelvir for acute COVID-19 to prevent long COVID (PANORAMIC Norway): a double-blind, randomised, placebo-controlled trial"],"prefix":"10.1016","author":[{"given":"Oddvar","family":"Oppegaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn","family":"Blomberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca Jane","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arild","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai Norevik","family":"Myklebust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marte","family":"Glambek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"T\u00f8ndel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuva B\u00f8rresdatter","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tori","family":"Friis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Mj\u00f8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne Emblem","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Sandvig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke","family":"Devold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Wilhelmsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Tr\u00f8seid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolv Terje","family":"Lie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l","family":"Aukrust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Langeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Szodoray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrine Sjaastad","family":"Hanssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marte","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oddvar","family":"Kaarb\u00f8e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle Torp","family":"Meszaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Stefan","family":"Olofsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Minde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Poltorak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S1473-3099(26)00244-6_bib1","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/s41591-021-01433-3","article-title":"Long COVID in a prospective cohort of home-isolated patients","volume":"27","author":"Blomberg","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/S1473-3099(26)00244-6_bib2","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1038\/s41591-023-02521-2","article-title":"Postacute sequelae of COVID-19 at 2 years","volume":"29","author":"Bowe","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/S1473-3099(26)00244-6_bib3","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S2215-0366(24)00214-1","article-title":"Cognitive and psychiatric symptom trajectories 2\u20133 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK","volume":"11","author":"Taquet","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/S1473-3099(26)00244-6_bib4","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1093\/cid\/ciac655","article-title":"Symptom burden and immune dynamics 6 to 18 months following mild severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2): a case-control study","volume":"76","author":"Fjelltveit","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S1473-3099(26)00244-6_bib5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41586-022-04569-5","article-title":"SARS-CoV-2 is associated with changes in brain structure in UK Biobank","volume":"604","author":"Douaud","year":"2022","journal-title":"Nature"},{"key":"10.1016\/S1473-3099(26)00244-6_bib7","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/s41591-024-03173-6","article-title":"Long COVID science, research and policy","volume":"30","author":"Al-Aly","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/S1473-3099(26)00244-6_bib8","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral nirmatrelvir for high-risk, nonhospitalized adults with COVID-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/S1473-3099(26)00244-6_bib9","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/jamainternmed.2024.2007","article-title":"Nirmatrelvir\u2013ritonavir and symptoms in adults with postacute sequelae of SARS-CoV-2 infection: the STOP-PASC randomized clinical trial","volume":"184","author":"Geng","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S1473-3099(26)00244-6_bib10","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S1473-3099(25)00073-8","article-title":"Nirmatrelvir\u2013ritonavir versus placebo\u2013ritonavir in individuals with long COVID in the USA (PAX LC): a double-blind, randomised, placebo-controlled, phase 2, decentralised trial","volume":"25","author":"Sawano","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S1473-3099(26)00244-6_bib11","article-title":"Association of COVID vaccinations and treatments with long COVID beyond 6 months: a case-control study on the adult population in a large integrated healthcare system in the United States from 2020 to 2023","volume":"57","author":"Liu","year":"2025","journal-title":"Prev Med Rep"},{"key":"10.1016\/S1473-3099(26)00244-6_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106190","article-title":"Early use of oral antiviral drugs and the risk of post COVID-19 syndrome: a systematic review and network meta-analysis","volume":"89","author":"Jiang","year":"2024","journal-title":"J Infect"},{"key":"10.1016\/S1473-3099(26)00244-6_bib13","article-title":"Real-world effectiveness of nirmatrelvir in protecting long COVID for outpatient adult patients\u2014a large-scale observational cohort study from the RECOVER Initiative","author":"Wang","year":"2024","journal-title":"Res Sq"},{"key":"10.1016\/S1473-3099(26)00244-6_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46912-4","article-title":"Nirmatrelvir\/ritonavir and risk of long COVID symptoms: a retrospective cohort study","volume":"13","author":"Congdon","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/S1473-3099(26)00244-6_bib15","article-title":"CONSORT 2025 statement: updated guideline for reporting randomised trials","volume":"389","author":"Hopewell","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/S1473-3099(26)00244-6_bib16","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s13063-025-09226-6","article-title":"Randomized trial of nirmatrelvir\/ritonavir versus placebo for adults with acute COVID-19 to prevent long COVID: PanoramicNOR trial","volume":"26","author":"Blomberg","year":"2025","journal-title":"Trials"},{"key":"10.1016\/S1473-3099(26)00244-6_bib17","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","article-title":"A clinical case definition of post-COVID-19 condition by a Delphi consensus","volume":"22","author":"Soriano","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S1473-3099(26)00244-6_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0022-3999(93)90081-P","article-title":"Development of a fatigue scale","volume":"37","author":"Chalder","year":"1993","journal-title":"J Psychosom Res"},{"key":"10.1016\/S1473-3099(26)00244-6_bib19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1473-3099(24)00431-6","article-title":"Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial","volume":"25","author":"Harris","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S1473-3099(26)00244-6_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf567","article-title":"Risk of post-COVID-19 conditions among adolescents and adults who received nirmatrelvir\u2013ritonavir for acute COVID-19: a retrospective cohort study","volume":"12","author":"Dalton","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/S1473-3099(26)00244-6_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004711","article-title":"Effect of Paxlovid treatment during acute COVID-19 on long COVID onset: an EHR-based target trial emulation from the N3C and RECOVER consortia","volume":"22","author":"Preiss","year":"2025","journal-title":"PLoS Med"},{"key":"10.1016\/S1473-3099(26)00244-6_bib22","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/jamainternmed.2023.0743","article-title":"Association of treatment with nirmatrelvir and the risk of post-COVID-19 condition","volume":"183","author":"Xie","year":"2023","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S1473-3099(26)00244-6_bib23","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/infdis\/jiac136","article-title":"Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review","volume":"226","author":"Chen","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/S1473-3099(26)00244-6_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2024.1320059","article-title":"Symptom trajectories of post-COVID sequelae in patients with acute delta or omicron infection in Bergen, Norway","volume":"12","author":"Iversen","year":"2024","journal-title":"Front Public Health"},{"key":"10.1016\/S1473-3099(26)00244-6_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/S1473-3099(26)00244-6_bib26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(23)00493-0","article-title":"Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial","volume":"24","author":"Schilling","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S1473-3099(26)00244-6_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2025.102994","article-title":"Post COVID-19 condition phenotypes: a prospective cohort study identifying four symptom clusters and their impact on long-term outcomes","volume":"18","author":"Grafstr\u00f6m","year":"2025","journal-title":"J Infect Public Health"},{"key":"10.1016\/S1473-3099(26)00244-6_bib28","article-title":"Statistically significant results from low-power analyses: a comedy of errors","volume":"11","author":"Jaksic","year":"2026","journal-title":"Glob Epidemiol"}],"container-title":["The Lancet Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473309926002446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473309926002446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T07:26:51Z","timestamp":1786087611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473309926002446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":27,"alternative-id":["S1473309926002446"],"URL":"https:\/\/doi.org\/10.1016\/s1473-3099(26)00244-6","relation":{},"ISSN":["1473-3099"],"issn-type":[{"value":"1473-3099","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nirmatrelvir for acute COVID-19 to prevent long COVID (PANORAMIC Norway): a double-blind, randomised, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1473-3099(26)00244-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S1473-3099(26)00361-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}